Novavax COVID-19 Vaccine, Adjuvanted
Novavax COVID-19 Vaccine, Adjuvanted is available under EUA to prevent COVID-19 in individuals 12 years of age and older.
The vaccine is authorized for emergency use as a two-dose primary series. The two doses are given three weeks apart.
Novavax COVID-19 Vaccine, Adjuvanted contains the SARS-CoV-2 spike protein and Matrix-M adjuvant. Adjuvants are incorporated into some vaccines to enhance the immune response of the vaccinated individual. The spike protein in this vaccine is produced in insect cells; the Matrix M-adjuvant contains saponin extracts from the bark of the Soapbark tree that is native to Chile.
Common Side Effects
The most commonly reported side effects by vaccine recipients included pain/tenderness, redness and swelling at the injection site, fatigue, muscle pain, headache, joint pain, nausea/vomiting and fever. Read more about side effects on the Fact Sheet for Recipients and Caregivers.
Fact Sheets (English)
| Information | Last Updated |
|---|---|
| Fact Sheet for Healthcare Providers Administering Vaccine | August 19, 2022 |
| Fact Sheet for Recipients and Caregivers | August 19, 2022 |
Regulatory Information
| Information | Date |
|---|---|
| Letter of Authorization (reissued) | August 19, 2022 |
| Decision Memorandum | July 13, 2022 |
| Advisory Committee Meeting Information | June 7, 2022 |
Media Materials
| Information | Date |
|---|---|
| FDA Roundup | August 19, 2022 |
| Press Release | July 13, 2022 |
| Advisory Committee Meeting Webcast | June 7, 2022 |
Translations of the Fact Sheet for Recipients and Caregivers
| 接受者和护理者须知 (July 13, 2022) |
中文 (Chinese, Simplified) |
| 환자와 의료진을 위한 정보지 (July 13, 2022) |
한국어 (Korean) |
| HOJA INFORMATIVA PARA RECEPTORES Y PROVEEDORES DE CUIDADO (July 13, 2022) |
Español (Spanish) |
| FACT SHEET PARA SA MGA TATANGGAP AT MGA TAGAPAG-ALAGA (July 13, 2022) |
Tagalog (Tagalog) |
| TỜ THÔNG TIN CHO NGƯỜI NHẬN VÀ NHỮNG NGƯỜI CHĂM SÓC (July 13, 2022) |
Tiếng Việt (Vietnamese) |